BCR and neoplasm: In fact, aberrant BCR signaling in CLL drives a complex interplay between the leukemic cells and their tumor microenvironment (TME), involving cross-talks with accessory T lymphocytes, macrophages, and stromal cells (Figure 3) [73,74].